Number of the records: 1  

dasatinib

  1. Topical termdasatinib
    See link(18F)-N-(2-chlor-6-methyl-fenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-4-ylamino)thiazol-5-karboxamid (UF)
    (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (UF)
    BMS 354825 (UF)
    BMS-354825 (UF)
    BMS354825 (UF)
    C22H26N7ClO2S (UF)
    N-(2-chlor-6-methyl-fenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-4-ylamino)thiazol-5-karboxamid (UF)
    N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (UF)
    Sprycel (UF)
    See alsopyrimidiny
    thiazoly
    antitumorózní látky (PA)
    inhibitory tyrosinkinasy (PA)
    Linking entryDasatinib
    ConspectD02. - 886. - 675. - 184
    D03. - 383. - 129. - 708. - 198
    D03. - 383. - 742. - 148
    NoteA pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB.
    DatabaseMESH
    References (2) - MESH
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all